|
Volumn 34, Issue 6, 2006, Pages 1323-1326
|
The ALIAS (ALbumin in Acute Stroke) Phase III randomized multicentre clinical trial: Design and progress report
|
Author keywords
Albumin; Focal cerebral ischaemia; Neuroprotection; Randomized clinical trial; Stroke; Thrombolysis
|
Indexed keywords
ALTEPLASE;
HUMAN ALBUMIN;
PLACEBO;
SERUM ALBUMIN;
ACUTE DISEASE;
BLOOD CLOT LYSIS;
BRAIN HEMORRHAGE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
DRUG DOSE ESCALATION;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG TOLERABILITY;
HEALTH CARE COST;
HUMAN;
LUNG EDEMA;
MULTICENTER STUDY;
NEUROPROTECTION;
PATIENT MONITORING;
PREVALENCE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STROKE;
TREATMENT OUTCOME;
ARTICLE;
CONTROLLED STUDY;
METHODOLOGY;
MONITORING;
PHASE 3 CLINICAL TRIAL;
PILOT STUDY;
ANIMALIA;
CEREBROVASCULAR ACCIDENT;
HUMANS;
MONITORING, PHYSIOLOGIC;
PILOT PROJECTS;
RESEARCH DESIGN;
SERUM ALBUMIN;
TREATMENT OUTCOME;
|
EID: 34248639061
PISSN: 03005127
EISSN: None
Source Type: Journal
DOI: 10.1042/BST0341323 Document Type: Conference Paper |
Times cited : (40)
|
References (23)
|